Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Quantify Research (QUANTIFY) announced their expansion into Denmark and Norway to expand the breadth and depth of their Nordic service offerings. QUANTIFY is a global partner to the life science industry in the development of real-world evidence ...
read more
Formedix, a leading provider of clinical trial software solutions, has collaborated with CDISC, the global clinical research data standards development organization, to create a novel portal providing free access to ready-to-use, CDASH-compliant, ...
read more
SGD Pharma’s 20ml EasyLyo molded glass Type I vials are now available Ready-to-Use (RTU) in SG EZ-fill® Nest & Tub – an industry-recognized state-of-the-art secondary packaging format. Increased demand for parenteral drugs generated by the Covid-19 ...
read more
MRO, a leading clinical data workflow platform and the KLAS-rated No. 1 provider of release of information (ROI) solutions, announced the acquisition of Rockford, IL-based FIGmd, a leading provider of clinical, claims and quality data acquisition ...
read more
BSI, a business improvement and standards company, announced a collaborative partnership with Poseidon, an independent pharmaceutical logistics network, with the objective of bringing greater quality, and certainty to the global distribution of ...
read more
The increasing need for speed and efficiency in clinical research has created more urgency to streamline and simplify the patient journey. Trialbee, a patient matching and enrolment platform, and uMotif, a patient-centric data capture provider, are ...
read more
Sygnature Discovery announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line expands the company’s portfolio into formal preclinical drug development. A new world-class facility with ...
read more
KBI Biopharma Inc., a JSR Life Sciences company, and AM-Pharma, an emerging leader focused on the development of therapeutics that protect organ function in patients with severe medical conditions, have signed a commercial manufacturing agreement to ...
read more
Quanticate, a leading global data-focused clinical research organization (CRO), has engineered a new Remote Source Data Verification (RSDV) Platform. The 21 CFR part 11 compliant cloud-based application allows verification of multiple clinical ...
read more
ViiV Healthcare and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement that gives exclusive access to Halozyme’s ENHANZE® drug delivery technology, recombinant human hyaluronidase PH20 enzyme (rHuPH20), for specific ...
read more
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
IRISYS, LLC, a San Diego-based contract pharmaceutical development and manufacturing services company, announced that it has been issued U.S. Patent No. 11,033,530, Liposomal Anticancer Compositions. IRISYS scientists discovered a new way to deliver ...
read more
Syneos Health® expanded its Decentralized Clinical Trial capabilities to include a dedicated Decentralized Clinical Trials Site Advocacy Group, continuing the momentum for Decentralized Solutions demonstrated by the recent acquisition of Illingworth ...
read more
ProBioGen and LAVA Therapeutics N.V. announced the closing of a second cell line development agreement to support a bispecific gamma-delta T cell engager (TCE) candidate in LAVA's pipeline.
read more
ValenzaBio, a biopharmaceutical company developing monoclonal antibody therapeutics for autoimmune and inflammatory indications, and Lonza announced that the companies have a manufacturing agreement in place.
read more